David Ting

David Ting has extensive work experience in the field of cancer research and medicine. David currently holds positions at the Mass General Cancer Center and Harvard Medical School. At Mass General Cancer Center, they serve as the Co-Director of the Biomarker Discovery Lab and the Associate Clinical Director for Innovation. At Harvard Medical School, they are an Associate Professor of Medicine and an MD Faculty Advisor. David has also served as an Assistant Professor and a Founder at various organizations, including TellBio, Inc., ROME Therapeutics, and PanTher Therapeutics. In addition, they have held roles at the Harvard Medical School Division of Health Sciences and Technology and the Massachusetts General Hospital Cancer Center. David began their career as a Post-doctoral Research Fellow at the Daniel Haber Lab, where they focused on various cancer research projects. David also completed an Oncology Fellowship at the Dana Farber Cancer Institute and a residency at Massachusetts General Hospital.

David Ting completed their Bachelor of Science degree in Chemical Engineering and Biology from the Massachusetts Institute of Technology (MIT) from 1995 to 1999. David went on to attend Harvard Medical School from 1999 to 2004, where they obtained their MD degree with a focus on Medicine.